Equity
€750,318 ▲ 18.5%
FAGEDIS has made a profit without a break since 2019.
FAGEDIS
Lifetime
21 annual accounts with figures on one time axis, 25 filings since 2000peak €565,573 (2024)
€514,304▼ 9.1%
lowest -€505,648 (2012)
€167,315▼ 25.8%
peak €1.1m (2009)
€750,318▲ 18.5%
€535,552▼ 13.4%
peak 4.4 FTE (2024)
4.2 FTE▼ 4.5%
Board7 names since 2014
1 director
Documentsfilings and deeds
20-07-202611 days before the deadline
2025abbreviated format
Result from €225,554 to €167,3152 directors appointed, 2 resignations 22-07Equity from €633,003 to €750,318Investments €300,902Cash from €227,633 to €89,624
Key points
from the 2025 annual accountsTurnover
≈ €1.8m estimated
The accounts state no turnover.
Investments
€302,666 3.1 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 35.5% higher than in 2024.
Staff
7 employees on 31-12-2025
In 2025, 39 people joined and 36 left.
Liquidity
1.97 was 1.21 in 2024
Short-term debts fell from €602,981 to €285,524.
Filings
25 annual accounts since 2000
Six of the last ten came late. The 2021 accounts came latest: 89 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as FAGEDIS has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for FAGEDIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0469721807
2 directors appointed, 2 resignations
Resignations: (managing director) and (managing director) · Appointments: and · Permanent representative: · General meeting of 01-07-2025 · Gazette deed
Capital decrease of €500,000 to €220,000
Capital from €720,000 to €220,000 · Change of role: , from director to chair of the board · Resignation: (director) · General meeting of 21-12-2022 · Gazette deed
Reappointments: (director) and (director)
General meeting of 25-07-2019 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FAGEDIS Seneffe | €1.3m | €514,304 | 58.4% | 4.2 |
| PHARMACIE MARIE RENAUX Charleroi | €1.4m | €504,535 | 43.1% | 4.7 |
| PHARMACIE LIPPINOIS Brunehaut | €1.4m | €423,532 | 30.2% | 4 |
| PHARMACIE SENEFFE CENTRE Seneffe | €1.5m | €576,922 | 39.9% | 4 |
| PHARMACIE VALERIE VERDINNE Charleroi | €1.1m | €560,844 | 59.8% | 4.9 |
| PHARMACIE DE BASCOUP Seneffe | €1.6m | €517,152 | 27.4% | 3.8 |
| PHARMACIE LAMBION-LAMALLE Liège | €1.3m | €524,362 | 84.8% | 3.6 |
These companies have the same main activity as FAGEDIS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.6m, founded between 1996 and 2002.
Official details
Source: KBO- Status
- Active since 14-01-2000Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.096.365.7807181 Seneffe, since 03-02-2000
- Financial year end
- 31 December
- Peppol
- Reachable since 02-10-2025
Annual accounts 2025
- €1.3m▲ 2.8%
- Employeeson 31-12-2025
- 7▲ 75.0%
- Filing
- Filed on 20-07-2026, 11 days before the end of the filing period
Insights on FAGEDIS
FAGEDIS files the abbreviated format. That format states no turnover. The gross margin rose from €359,380 in 2005 to €514,304 in 2025.
The balance sheet grew most from 2024 to 2025 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FAGEDIS
- What is the company number of FAGEDIS?
- The company number of FAGEDIS is 0469.721.807. The VAT number is the same number with BE in front: BE 0469.721.807.
- Where is FAGEDIS based?
- The registered office is at Grand-Place de Feluy 17, 7181 Seneffe.Company details
- What does FAGEDIS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of FAGEDIS?
- FAGEDIS is a public limited company (NV).
- When was FAGEDIS founded?
- FAGEDIS was founded on 14-01-2000.
- Is FAGEDIS still active?
- Yes, FAGEDIS is an active enterprise in the KBO register.
- How many employees does FAGEDIS have?
- FAGEDIS had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does FAGEDIS fall under?
- In its 2025 annual accounts, FAGEDIS states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of FAGEDIS?
- The turnover in financial year 2025 is ≈ €1.8m. This figure is estimated from the gross margin of €514,304 and 42 comparable companies (NACE 477). It probably lies between €1.4m and €2.5m.
- Is FAGEDIS profitable?
- In financial year 2025, FAGEDIS made a profit of €167,315.
- Where can I find the annual accounts of FAGEDIS?
- FAGEDIS filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FAGEDIS due?
- FAGEDIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.